Single‐Dose Pharmacokinetics of Nizatidine (Axid®) in Children
Autor: | Gregory B. Holmes, Gregory L. Kearns, Neil Manowitz, Franklin K. Johnson, Susan M. Abdel-Rahman |
---|---|
Rok vydání: | 2002 |
Předmět: | |
Zdroj: | The Journal of Clinical Pharmacology. 42:1089-1096 |
ISSN: | 1552-4604 0091-2700 |
DOI: | 10.1177/009127002237997 |
Popis: | The pharmacokinetics of nizatidine following a single 5.0 mg/kg oral dose given as an extemporaneous liquid formulation in apple juice was examined in 12 healthy children (8.0 +/- 2.4 years, 30.7 +/- 8.4 kg). Nizatidine and N-desmethylnizatidine were quantitated by HPLC/MS from five post dose blood samples taken over a 12-hour period. The apparent terminal elimination rate constant for nizatidine in the pediatric subjects (0.58 +/- 0.8h(-1)) was virtually identical to that (0.54 +/- 0.13 h(-1)) previously reported from adult studies. When corrected for an estimated 30% reduction in nizatidine oral bioavailability observed in adults upon coingestion of the drug with other fruit/vegetable juices, nizatidine pharmacokinetic parameter estimates (e.g., Cmax, CL/F, Vss/F) in our pediatric subjects were similar to those previously reported in adults who were administered dimensionally similar (e.g., approximately 4 mg/kg) solid oral doses of the drug. Examination of the mean area under the curve (i.e., AUC0-infinity for nizatidine and N-desmethylnizatidine suggested an approximate 15% metabolic conversion of the parent drug. Finally, nizatidine plasma concentrations in pediatric patients following a single 5.0 mg/kg oral dose exceeded the EC50 value of the drug for gastric acid suppression determined from adult studies for approximately 6 hours. |
Databáze: | OpenAIRE |
Externí odkaz: |